Navigation Links
OncoGenex Announces Publication of Custirsen Phase II Clinical and Pre-Clinical Data in Leading Cancer Journals
Date:9/6/2011

BOTHELL, Wash. and VANCOUVER, British Columbia, Sept. 6, 2011 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that data from two studies, a Phase II clinical study and a pre-clinical study, evaluating the investigational compound custirsen (OGX-011/TV-1011), were published in the September issues of the journals Clinical Cancer Research and Cancer Research.

Custirsen inhibits the production of clusterin, a protein commonly over-produced in cancer cells and a cause of treatment resistance. Two Phase III studies evaluating custirsen in men with castrate-resistant prostate cancer (CRPC) are ongoing: the SYNERGY clinical trial - designed to evaluate an overall survival benefit for custirsen in combination with first-line docetaxel treatment, and the Prostate Cancer SATURN Trial - which will evaluate a durable pain palliation benefit in patients receiving second-line chemotherapy. Both studies are currently enrolling CRPC patients.

Phase II Data Published in Clinical Cancer Research

Data from a Phase II clinical study of custirsen in combination with docetaxel retreatment or mitoxantrone as second-line chemotherapy in patients with metastatic castrate-resistant prostate cancer (mCRPC) was published in the September 1, 2011 issue of Clinical Cancer Research.

In the clinical study, custirsen combined with docetaxel retreatment resulted in overall survival of 15.8 months. When custirsen was combined with mitoxantrone, overall survival was 11.5 months. The Phase II study also evaluated pain responses in patients with mCRPC. Overall, the pain response was durable (greater than or equal to three months) in 88 percent of patients who had pain or were on opioids for pain at study entry.

"These are encouraging results because we observed durable pain responses in many patients who had di
'/>"/>

SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. OncoGenex Pharmaceuticals Names Michelle Burris Executive Vice President, Operations and Chief Financial Officer
2. OncoGenex Reports Third Quarter Financial Results
3. OncoGenex Pharmaceuticals, Inc. Closes $50 Million Public Offering
4. OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering
5. OncoGenex Pharmaceuticals, Inc. Announces Proposed Public Offering
6. OncoGenex Pharmaceuticals to Present at the 9th Annual BIO Investor Forum
7. TEVA AND ONCOGENEX ANNOUNCE INITIATION OF SECOND PHASE 3 TRIAL OF CUSTIRSEN IN MEN WITH METASTATIC PROSTATE CANCER
8. OncoGenex Pharmaceuticals, Inc. - Journal of Clinical Oncology Publishes Data from Randomized Phase 2 Custirsen Trial
9. OncoGenex Reports Second Quarter Financial Results
10. OncoGenex Pharmaceuticals Announces Initiation of a Phase 3 Trial in Men with Metastatic Prostate Cancer
11. OncoGenex Pharmaceuticals to Present at the 9th Annual Needham Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... a new way of manufacturing microstructured surfaces that ... self-assembly of carbon nanotubes, could exhibit a variety ... and strength, or the ability to repel water ... that mechanical forces can be used to direct ... we can independently control the mechanical properties ...
(Date:7/29/2014)... 29, 2014  Discovery Laboratories, Inc. (Nasdaq: DSCO),  ... new standard of respiratory critical care, will report its ... 2014 before the open of the U.S. financial ... a live teleconference and webcast at 9:00 a.m. Eastern ... Discovery Labs, management will discuss the 2014 second ...
(Date:7/29/2014)... CO (PRWEB) July 29, 2014 TransVac ... soiled linen collection and transport solutions for hospitals, will ... for Healthcare Engineering (ASHE) Annual Conference & Technical Exhibition ... will present its technology for making hospitals cleaner, reducing ... costs over the hospital’s life cycle. Staff will ...
(Date:7/29/2014)... 2014 DisasterTalk is a texting app which ... phone masts or other transmitters are down. The app can ... without the need for any Wi-Fi, and can also use ... new app has launched as a housing report ... high risk of being affected by natural disasters. With the ...
Breaking Biology Technology:A new way to make microstructured surfaces 2Discovery Labs to Report 2014 Second Quarter Financial Results and Hold Conference Call on Tuesday, August 5, 2014 at 9:00 a.m. Eastern Time 2TransVac Presents Cost Saving Technology at ASHE Conference for Keeping Hospitals Cleaner 2DisasterTalk App Could Save Lives as Report Reveals 8% of US Homes at Very High Risk of Natural Disaster 2
... September 25 XTL,Biopharmaceuticals Ltd. (NASDAQ: XTLB ; ... Meeting ("AGM") and Extraordinary General Meeting,("EGM") was postponed for ... to the absence of a quorum. The postponed AGM ... Kiryat Weizmann Science Park,Rehovot, Israel 76100 at 4:00 pm ...
... REHOVOT, Israel, Sept. 25 ,Monsanto Company (NYSE: ... announced,a collaboration to improve nitrogen use efficiency in ... gains exclusive rights to,a number of genes discovered ... applications of nitrogen. Monsanto will work to evaluate ...
... Plc, a,private biopharmaceutical company focusing on first-in-class, ... appointed Dr.,Johnson Lau and Dr. David Sidransky ... Johnson Lau (MBBS, MD, FRCP) brings a ... corporate fields, having a distinguished,background in both ...
Cached Biology Technology:XTL Biopharmaceuticals Ltd. AGM / EGM Postponed Until October 2, 2007 2Monsanto and Evogene Collaborate on Nitrogen Use Efficiency Research 2Monsanto and Evogene Collaborate on Nitrogen Use Efficiency Research 3Morria Biopharmaceuticals Plc Appoints Dr. Johnson Lau and Dr. David Sidransky to Board of Directors 2
(Date:7/29/2014)... bacteria and algae, propel themselves using whip-like appendages ... a millimetre long, function like tiny oars, helping ... cilia are found on the surfaces of many ... liquids over the cell. , Flagella and ... expel pathogens from our airways, they establish the ...
(Date:7/28/2014)... by the University of Arizona has sequenced the complete ... enhance scientists, and agriculturalists, understanding of the growing patterns ... of new rice varieties that are better able to ... hunger challenges. , The paper, "The genome sequence of ... independent domestication," was published online in Nature Genetics ...
(Date:7/28/2014)... A study of juvenile rat brain cells suggests that ... the connections between brain cells are temporary. , The ... PLOS ONE , was conducted by biologists at ... Medical College in New York in response to concerns, ... decade, that exposing children to general anesthetics may increase ...
Breaking Biology News(10 mins):Microscopic rowing -- without a cox 2Microscopic rowing -- without a cox 3Generating a genome to feed the world: UA-led team sequences African rice 2Generating a genome to feed the world: UA-led team sequences African rice 3Generating a genome to feed the world: UA-led team sequences African rice 4Study suggests disruptive effects of anesthesia on brain cell connections are temporary 2Study suggests disruptive effects of anesthesia on brain cell connections are temporary 3
... Salk Institute Laboratory of Genetics and holder of the ... Neurodegenerative Diseases, has been named a 2011 recipient of ... Research Projects (T-R01) program. Only 17 T-R01 projects ... with a total of $15.9 million in funding. Gage, ...
... has been published in the journal Coral Reefs by Giacomo Bernardi, ... Santa Cruz. In the video, an orange-dotted tuskfish digs ... rock, and repeatedly throws the clam against the rock to crush ... "What the movie shows is very interesting. The animal excavates sand ...
... be linked to the decline of water calcium levels ... that helps keep blooms at bay. Daphniaalso known ... on algae and keeping it in check. However, without ... water calcium levels get low and Daphnia populations decrease ...
Cached Biology News:Video shows tool use by a fish 2Loss of 'lake lawnmowers' leads to algae blooms 2
... Bruker Daltonics and Bruker BioSpins ... for metabolism studies, and analysis of ... ESI-TOF system, an optional Avance NMR ... acquisition, evaluation and statistical analysis for ...
... Morris Water MazeRecords animal movements in a ... subjects at once in a predefined sequence of ... instruments all built around a video camera, frame ... track two fields at once and up to ...
... Records behavior directed toward examining a novel object ... family of instruments all built around a video ... that can track two fields at once and ... extracts animal positions and records them, but also ...
... Grade C 19 H 9 Br 4 ... SPECIFICATIONS Form: Powder Clarity of Solution: Passes ... - Yellow pH 4.6 - Blue ... agarose and acrylamide gel electrophoresis. Used in ...
Biology Products: